These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34689063)

  • 1. Effects of a single bolus of hydroxocobalamin on hemodynamics in vasodilatory shock.
    Ritter LA; Maldarelli M; McCurdy MT; Yamane DP; Davison D; Parrino C; Yim DN; Lee M; Mazzeffi MA; Chow JH
    J Crit Care; 2022 Feb; 67():66-71. PubMed ID: 34689063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue.
    Brokmeier HM; Seelhammer TG; Nei SD; Gerberi DJ; Mara KC; Wittwer ED; Wieruszewski PM
    J Cardiothorac Vasc Anesth; 2023 Sep; 37(9):1757-1772. PubMed ID: 37147207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series.
    Shah PR; Reynolds PS; Pal N; Tang D; McCarthy H; Spiess BD
    Can J Anaesth; 2018 May; 65(5):560-568. PubMed ID: 29209927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized trial of intravenous hydroxocobalamin versus whole blood transfusion compared to no treatment for Class III hemorrhagic shock resuscitation in a prehospital swine model.
    Bebarta VS; Garrett N; Boudreau S; Castaneda M
    Acad Emerg Med; 2015 Mar; 22(3):321-30. PubMed ID: 25731610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized trial of intravenous hydroxocobalamin versus noradrenaline or saline for treatment of lipopolysaccharide-induced hypotension in a swine model.
    Bebarta VS; Garrett N; Maddry JK; Arana A; Boudreau S; Castaneda M; Dixon P; Tanen DA
    Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):216-225. PubMed ID: 30575111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the editor: Effects of a single bolus of hydroxocobalamin on hemodynamics in vasodilatory shock.
    Vollmer NJ; Seelhammer TG; Wittwer ED; Nabzdyk CG; Nei SD
    J Crit Care; 2022 Oct; 71():154046. PubMed ID: 35472601
    [No Abstract]   [Full Text] [Related]  

  • 7. High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial).
    Patel JJ; Willoughby R; Peterson J; Carver T; Zelten J; Markiewicz A; Spiegelhoff K; Hipp LA; Canales B; Szabo A; Heyland DK; Stoppe C; Zielonka J; Freed JK
    Chest; 2023 Feb; 163(2):303-312. PubMed ID: 36174744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxocobalamin in Refractory Septic Shock: A Retrospective Case Series.
    Sacco AJ; Cunningham CA; Kosiorek HE; Sen A
    Crit Care Explor; 2021 Apr; 3(4):e0408. PubMed ID: 33912838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory shock with vitamin B
    Wedemire C; Samavat H; Newkirk M; Parker A
    Nutr Clin Pract; 2024 Apr; 39(2):356-365. PubMed ID: 38030578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.
    Armour S; Armour TK; Joppa WR; Maltais S; Nelson JA; Wittwer E
    Anesth Analg; 2019 Jul; 129(1):e1-e4. PubMed ID: 29979199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraosseous hydroxocobalamin versus intravenous hydroxocobalamin compared to intraosseous whole blood or no treatment for hemorrhagic shock in a swine model.
    Bebarta VS; Garrett N; Boudreau S; Castaneda M
    Am J Disaster Med; 2015; 10(3):205-15. PubMed ID: 26663304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of High-Dose Hydroxocobalamin for Septic Shock: A Case Report.
    Lin Y; Vu TQ
    A A Pract; 2019 May; 12(9):332-335. PubMed ID: 30431443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxocobalamin for treatment of catecholamine-resistant vasoplegia during liver transplantation: A single-center series of 20 cases.
    Boettcher BT; Woehlck HJ; Makker H; Pagel PS; Freed JK
    Int J Surg Case Rep; 2022 Sep; 98():107488. PubMed ID: 35981485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A correlation of pulse pressure and prognosis of refractory septic shock patients].
    Li S; Wan X; Zhang Y; Dai X; Li Q; Han L; Deng Q
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):121-6. PubMed ID: 24767164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of hydroxocobalamin in conscious dogs.
    Riou B; Gérard JL; La Rochelle CD; Bourdon R; Berdeaux A; Giudicelli JF
    Anesthesiology; 1991 Mar; 74(3):552-8. PubMed ID: 2001034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Dose Hydroxocobalamin for Refractory Vasoplegia Post Cardiac Surgery.
    Bak MA; Smith JA; Murfin B; Chen Y
    Cureus; 2022 Aug; 14(8):e28267. PubMed ID: 36039127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
    Feih JT; Rinka JRG; Zundel MT
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation.
    An SS; Henson CP; Freundlich RE; McEvoy MD
    Am J Transplant; 2018 Jun; 18(6):1552-1555. PubMed ID: 29573551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
    Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
    J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery.
    Seelhammer TG; Plack D; Nei S; Wittwer E; Nelson J; Nabzdyk CGS
    Heart Lung; 2021; 50(2):173-176. PubMed ID: 33242823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.